Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn T Stebbins

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
International Review of Neurobiology|June 22, 2020
Determinants of placebo effectsSharlet Anderson, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|May 21, 2021
Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?Christopher G Goetz, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tapeChristopher G Goetz, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|April 23, 2020
Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 EraChristopher G Goetz, Glenn T Stebbins, Sheng Luo
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2018
What influences placebo and nocebo responses in Parkinson's disease?Natalie Witek, Glenn T Stebbins, Christopher G Goetz
Journal of Huntington'S Disease|October 8, 2025
Reply to: In Response to Fuller et al., Functional Rating Scale 2.0 (FuRST 2.0): A patient-reported outcome measure of function for Huntington's diseaseNeha Sinha, Rebecca Lm Fuller, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2011
Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 yearsChristopher G Goetz, Glenn T Stebbins, Bichun Ouyang
Movement Disorders : Official Journal of the Movement Disorder Society|October 16, 2004
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative modelNico J Diederich, Christopher G Goetz, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|October 26, 2011
Dopamine dysregulation syndrome item from the MDS-UPDRSChristopher G Goetz, Barbara C Tilley, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|August 14, 2012
Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scoresChristopher G Goetz, Glenn T Stebbins, Barbara C Tilley
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
International Review of Neurobiology|June 22, 2020
Determinants of placebo effectsSharlet Anderson, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|May 21, 2021
Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?Christopher G Goetz, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tapeChristopher G Goetz, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|April 23, 2020
Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 EraChristopher G Goetz, Glenn T Stebbins, Sheng Luo
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2018
What influences placebo and nocebo responses in Parkinson's disease?Natalie Witek, Glenn T Stebbins, Christopher G Goetz
Journal of Huntington'S Disease|October 8, 2025
Reply to: In Response to Fuller et al., Functional Rating Scale 2.0 (FuRST 2.0): A patient-reported outcome measure of function for Huntington's diseaseNeha Sinha, Rebecca Lm Fuller, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2011
Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 yearsChristopher G Goetz, Glenn T Stebbins, Bichun Ouyang
Movement Disorders : Official Journal of the Movement Disorder Society|October 16, 2004
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative modelNico J Diederich, Christopher G Goetz, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|October 26, 2011
Dopamine dysregulation syndrome item from the MDS-UPDRSChristopher G Goetz, Barbara C Tilley, Glenn T Stebbins
Movement Disorders : Official Journal of the Movement Disorder Society|August 14, 2012
Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scoresChristopher G Goetz, Glenn T Stebbins, Barbara C Tilley
Pageof 22